HOME >> MEDICINE >> NEWS
Antibiotics within 4 hours of arrival at hospital better for pneumonia patients

CHICAGO Giving older patients antibiotics within four hours of their arrival at a hospital for treatment of pneumonia reduces the length of hospital stay, and may reduce the chances of dying, according to an article in the March 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

According to the article, pneumonia is the second leading reason for hospitalization among Medicare beneficiaries, accounting for more than 600,000 Medicare hospitalizations yearly, and is the fifth leading cause of death among Americans older than 65 years. Timely administration of antibiotics to hospitalized patients with pneumonia has been associated with improved survival, the article states. Guidelines recommend antibiotic treatment within eight hours of arrival at a hospital.

Peter M. Houck, M.D., from the Centers for Medicare & Medicaid Services, Seattle, and colleagues investigated whether administration of antibiotics within less than eight hours of arrival at the hospital was associated with significant improvements in hospitalized patients with pneumonia who had not been treated prior to arriving at the hospital.

The researchers examined medical records from a national random sample of 18,209 Medicare patients older than 65 years who were hospitalized with pneumonia from July 1998 through March 1999.

Among the 13,771 (75.6 percent) of patients who did not receive any treatment prior to their arrival at a hospital, antibiotic administration within four hours of arrival was associated with reduced death in the hospital (6.8 percent vs. 7.4 percent), reduced likelihood of dying within 30 days of admission to the hospital (11.6 percent vs. 12.7 percent) and reduced likelihood that the length of stay (LOS) at the hospital exceeded 5 days (42.1 percent vs. 45.1 percent). The average length of stay was an average of about half a day shorter for patients who received antibiotics within four hours of arriving at the
'"/>

Contact: Centers for Medicare & Medicaid Services
202-690-6145
JAMA and Archives Journals
22-Mar-2004


Page: 1 2

Related medicine news :

1. Antibiotics protect nerves in mice by turning on genes
2. Antibiotics not always beneficial for childhood ear infections
3. Antibiotics help heart patients
4. Antibiotics Reduce Inflammation In Heart Disease But Effect On Heart Attacks Remains Unproven
5. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats
6. Researchers Synthesize Compounds For New Class Of Antibiotics
7. Physicists find patterns within seemingly random events of physiological systems
8. Scientists discover enzyme crucial to the transportation of proteins within cells
9. Non-drug treatment device delivers sustained blood pressure reductions within 3-4 weeks in the home
10. Bone cells help call the shots for the bloods stem cells within
11. Evaluation needed to gauge silent threat lurking within stroke patients

Post Your Comments:
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation (IDF) ... community using its IDF ePHR, an electronic personal health record powered by Get ... easily track their health information, including symptoms, diagnoses, medications, infusions and other critical ...
(Date:7/7/2015)... ... 07, 2015 , ... Parents and guardians of teenagers or young adults will ... holistic treatment center for drug and alcohol abuse located in Southwest Michigan. A recently ... shown a significant increase in the “club drug” use among high school seniors. The ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... of telemedicine programs in communities throughout Georgia, announces the launch of the first ... rural communities of Hancock County, GA. The new program will not only provide ...
(Date:7/7/2015)... NH (PRWEB) , ... July ... ... integrated, full-service public relations, marketing, and creative design firm, today announced that ... regional public relations and social media campaign, content strategy, and marketing launch ...
(Date:7/7/2015)... Horsham, PA (PRWEB) , ... July 07, 2015 ... ... seasoned financial executive Ellen Purdy as the company’s new Chief Financial Officer, effective ... financial and leadership experience in companies ranging from a multi-billion dollar, global chemical ...
Breaking Medicine News(10 mins):Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering of 32,000,000 units. Each unit consists of one share ... purchase one share of common stock at a purchase ... units in the offering would result in them beneficially ...
(Date:7/7/2015)... July 7, 2015 Oasmia ... of drugs within human and veterinary oncology, today ... in the United States , ... leading companion animal therapeutic.      (Logo: ... ) , Paccal Vet-CA1 was ...
Breaking Medicine Technology:Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
Cached News: